Biotechnology is certainly on the list, if not at the top, of high-growth industries in dire need of a rebound. Following enthusiasm for COVID-19 vaccines in late 2020 and part of 2021, biotechnology stocks and ETFs have disappointed investors. The group’s slump is now prolonged, but it won’t be permanent. Investors considering preparation for biotech [...] The post Innovation Could Propel Biotechnology Bounce appeared first on ETF Trends .